Congenital long QT syndrome: Considerations for primary care physicians

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 8, 2008, Pages 591-600

  Levine, Ethan ^a   Rosero, Spencer Z ^a   Budzikowski, Adam S ^a   Moss, Arthur J ^a   Zareba, Wojciech ^a   Daubert, James P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

DECISION SUPPORT SYSTEM; DEFIBRILLATOR; ELECTROPHYSIOLOGY; FEMALE; GENERAL PRACTITIONER; GENETIC SCREENING; GENOTYPE; HUMAN; LONG QT SYNDROME; METHODOLOGY; MUTATION; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRIMARY HEALTH CARE; REVIEW; RISK ASSESSMENT; TIME;

ADRENERGIC BETA-ANTAGONISTS; DECISION SUPPORT SYSTEMS, CLINICAL; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGY; FEMALE; GENETIC SCREENING; GENOTYPE; HUMANS; LONG QT SYNDROME; MUTATION; PHYSICIANS, FAMILY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRIMARY HEALTH CARE; RISK ASSESSMENT; TIME FACTORS;

EID: 51349144733     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75.8.591     Document Type: Review

References (49)

1. Vincent MG. Long QT syndrome. Cardiol Clin 2000; 18:309-325.
2. Quaglini S, Rognoni C, Spazzolini C, Priori SG, Mannarino S, Schwartz PJ. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J 2006; 27:1824-1832.
3. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000; 101:616-623.
4. Schwartz P, Periti M, Malliani A. The long Q-T syndrome. Am Heart J 1975; 89: 378-390.
5. Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004; 292:1341-1344.
6. Jervell A, Lange-Neilsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957; 54:59-68.
7. Moss AJ, Schwartz PJ. 25th anniversary of the International Long QT Syndrome Registry: an ongoing quest to uncover the secrets of long QT syndrome. Circulation 2005; 111:1199-1201.
8. Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest 2005; 115:2025-2032.
9. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare in età pediatrica. Clin Pediatr 1963; 45:656-683.
10. Ward O. A new familial cardiac syndrome in children. J Ir Med Assoc 1964; 54: 103-106.
11. Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005; 294:2975-2980.
12. Zareba W. Genotype-specific ECG patterns in the long QT syndrome. J Electrocardiol 2006; 39:S101-S106.
13. Modell SM, Lehmann MH. The long QT syndrome family of cardiac ion channelopathies: A HuGE review. Genet Med 2006; 8:143-155.
14. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 2002; 17:43-51.
15. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlations in the long QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89-95.
16. Zygmunt AC. Intracellular calcium activates chloride current in canine ventricular myocytes. Am J Physiol 1994: 267:1984-1995.
17. Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2, and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000; 35:778-786.
18. Wilde AAM, Jongbloed RJE, Doevendans PA, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQT2) from KVLQT1-related patients (LQT1). J Am Coll Cardiol 1999; 33:327-332.
19. Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004; 3:276-283.
20. Van den Berg MP, Wilde AA, Viersma TJW, et al. Possible bradycardiac mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 2001; 12:630-636.
21. Moss AJ, Windle JR, Hall WJ, et al. Safety and efficacy of flecainide in subjects with long QT-3 syndrome (delta-KPQ) mutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol 2005: 10(suppl 4):59-66.
22. Rashba EJ, Zareba W, Moss AJ, et al. Influence of pregnancy on the risk for cardiac events in patients with long QT syndrome. Circulation 1998; 97:451-456.
23. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is "normal." J Cardiovasc Electrophysiol 2006; 17:333-336.
24. Moss AJ. Measurement of the QT interval and the risk associated vurith QTc interval prolongation: a review. Am J Cardiol 1993; 72:23B-25B.
25. Jouven X. Hagege A, Charron P, et al. Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart 2002; 88:153-157.
26. Kenigsberg DN, Khanal S, Kowalski M, Krishnan SC. Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol 2007; 49:1299-1305.
27. Halkin A, Roth A, Lurie I, Fish R, Belhassen B, Viskin S. Pauce-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome. J Am Coll Cardiol 2001; 38:1168-1174.
28. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004; 95:754-763.
29. Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest 2005; 115:2025-2032.
30. Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital lonq-QT syndrome. Circulation 2007; 115:2613-2620.
31. Vetter VL. Clues or miscues? How to make the right interpretation and correctly diagnose long-QT syndrome. Circulation 2007; 115:2595-2598.
32. Mason JW, Hancock EW, Gettes LS. Recommendations for the standardization and interpretation of the electrocardiogram: part II: electrocardiography diagnostic statement list: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Elecrocardiology. Circulation 2007: 115:1325-1332.
33. Viskin S. Drug challenge with epinephrine or isoproterenol for diagnosing a long QT syndrome: should we try this at home? J Cardiovasc Electrophysiol 2005; 16:285-287.
34. Schwartz PJ. The long QT syndrome. In: Kulbertus HE, Wellens HJJ, editors. Sudden Death. The Hague: Martinus Nijhoff, 1980:358-378.
35. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995; 92:2929-2934.
36. Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation 2006; 113:1385-1392.
37. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med 1998; 339:960-965.
38. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long QT syndrome. N Engl J Med 2003; 348:1866-1874.
39. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88:782-784.
40. Zareba W, Moss AJ, Daubert JP, et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003; 14:337-341.
41. Sauer AJ, Moss AJ, McNitt S, et al. Long QT syndrome in adults. J Am Coll Cardiol 2007; 49:329-337.
42. Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J 2007; 153:53-58.
43. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996; 78:703-706.
44. Silka MJ, Kron J, Dunnigan A, Dick M, 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993; 87:800-807.
45. Moss A, McDonald J. Unilateral cervicothoracic sympathetic gangli-onectomy for the treatment of long QT interval syndrome. N Engl J Med 1971; 285:903-904.
46. Heradien MJ, Goosen A, Crotti L, et al. Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? J Am Coll Cardiol 2006; 48:1410-1415.
47. Khositseth A, Tester DJ, Will ML, Bell CM, Ackerman MJ. Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome. Heart Rhythm 2004; 1:60-64.
48. Seth R, Moss AJ, McNitt S, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol 2007; 49:1092-1098.
49. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 2002; 137:501-504.